e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Atypical bacteria, fungal and parasitic infections of the lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Distribution of respiratory manifestations during the
Chlamidiae psittaci
infections
J. L. Videnovic-Ivanov, V. M. Vucinic, S. R. Filipovic, V. R. Zugic (Belgrade, Serbia And Montenegro)
Source:
Annual Congress 2005 - Atypical bacteria, fungal and parasitic infections of the lung
Session:
Atypical bacteria, fungal and parasitic infections of the lung
Session type:
Thematic Poster Session
Number:
2609
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. L. Videnovic-Ivanov, V. M. Vucinic, S. R. Filipovic, V. R. Zugic (Belgrade, Serbia And Montenegro). Distribution of respiratory manifestations during the
Chlamidiae psittaci
infections. Eur Respir J 2005; 26: Suppl. 49, 2609
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Atypical pathogens and respiratory tract infections
Source: Eur Respir J 2004; 24: 171-182
Year: 2004
Chlamydia pneumoniae and Mycoplasma pneumonia infection in children respiratory diseases
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021
Macrolide-resistant mycoplasma pneumoniae in respiratory tract infection and its clinical relevance
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Occurrence of Chlamydia trachomatis and Chlamydia pneumoniae in paediatric respiratory infections
Source: Eur Respir J 2009; 33: 360-367
Year: 2009
Molecular characterisation and clinical presentation of Mycoplasma pneumoniae lower respiratory tract infections in children
Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes
Year: 2018
Mycoplasma pneumoniae genotype is associated with severity of lower respiratory tract infections in children
Source: International Congress 2017 – Paediatric respiratory infections and immunity
Year: 2017
Fungal respiratory infections
Source: Annual Congress 2010 - Fungal respiratory infections
Year: 2010
Fungal respiratory infections
Source: International Congress 2017 – State of the art session: "Respiratory infections"
Year: 2017
Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways and exacerbations of bronchoobstructive diseases
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
Chlamydia species as a cause of community-acquired pneumonia in Canada
Source: Eur Respir J 2003; 21: 779-784
Year: 2003
Urinary antigen of S. pneumoniae in the microbiological diagnosis of lower respiratory tract infections
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Monitoring opportunistic microflora in patients with HIV infection and highlighting the significance of Streptococcus gr. viridans in the development of lower respiratory tract infections
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways in patients with bronchoobstructive diseases
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
Clinical relevance of
C. pseudodiphtheriticum
in lower respiratory tract specimens
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Chlamidia pneumoniae
and
Mycoplasma pneumoniae
infection of airways in patients with broncho-obstructive diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 409s
Year: 2005
The role of
Chlamydiae
spp. in respiratory infections
Source: Annual Congress 2005 - Difficult infections in the respiratory patient
Year: 2005
Clinical features of Mycoplasma pneumoniae infections in Bulgarian children
Source: Virtual Congress 2020 – Epidemiology of paediatric respiratory diseases
Year: 2020
Carbapenem-resistant pathogens in US patients hospitalized with respiratory infections
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018
Mycoplasma pneumoniae
and respiratory viruses in patients with protracted forms of acute bronchitis
Source: Eur Respir J 2001; 18: Suppl. 33, 139s
Year: 2001
Fungal respiratory infection
Source: International Congress 2014 – ME04 Fungal respiratory infection
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept